Showing results (321-330 of 367) with videos related to

Sort By:
Pageof 37
Cell Reports|March 29, 2018
Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian CancerTakeshi Fukumoto, Pyoung Hwa Park, Shuai Wu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 26, 2020
HIST1H2BB and MAGI2 Methylation and Somatic Mutations as Precision Medicine Biomarkers for Diagnosis and Prognosis of High-grade Serous Ovarian CancerBlanca L Valle, Sebastian Rodriguez-Torres, Elisabetta Kuhn, et al.
The American Journal of Surgical Pathology|September 5, 2014
GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utilityNatalie Banet, Allen M Gown, Ie-Ming Shih, et al.
The Journal of Pathology|March 22, 2014
A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma developmentCheryl A Sherman-Baust, Elisabetta Kuhn, Blanca L Valle, et al.
Cell Reports|December 9, 2020
Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives MetastasisHuihui Fan, Huda I Atiya, Yeh Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2019
Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor TherapyYoungran Park, M Herman Chui, Yohan Suryo Rahmanto, et al.
Cancer Research|December 18, 2025
Integrated Spatial Analysis Reveals the Molecular Landscape of Ovarian Precancerous LesionsTu-Yung Chang, Yen-Wei Chien, Szu-Hua Chen, et al.
Nature Communications|June 3, 2020
Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogrammingYohan Suryo Rahmanto, Wenjing Shen, Xu Shi, et al.
Nature Communications|February 15, 2019
Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatmentZhongyi Hu, Junzhi Zhou, Junjie Jiang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 26, 2016
Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the EvidenceMark E Sherman, Ronny I Drapkin, Neil S Horowitz, et al.
Pageof 37